Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report

Recent advances in melanoma therapy have influenced the management of metastatic patients. Inhibitors of the BRAF/MEK/ERK signaling cascade have been proven highly effective in the metastatic disease although displaying different side effects. Here, we report a patient with BRAF V600E-mutated stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Orouji, Elias, Ziegler, Birgit, Umansky, Viktor, Gebhardt, Christoffer, Utikal, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603073/
https://www.ncbi.nlm.nih.gov/pubmed/25526431
http://dx.doi.org/10.1097/MD.0000000000000161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603073/
https://www.ncbi.nlm.nih.gov/pubmed/25526431
http://dx.doi.org/10.1097/MD.0000000000000161

Ejemplares similares